In this free webinar, learn about the growing consumer need for novel digestive health therapies, including a unique case study on the impact of a select probiotic and postbiotic on the health of individuals suffering from digestive ailments such as diarrhea-predominant irritable bowel syndrome. The featured speaker will discuss how unique probiotics and postbiotics are changing the digestive health landscape.
TORONTO, May 16, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar discussing the link between digestive health and pro-/post-biotics using data from the first human clinical data on patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
Increasingly, pre-clinical and clinical research supports the importance of gut health in a wide variety of physiological systems, ranging from digestive health and immune function support to cardiovascular and mental health. With nearly 80 percent of consumers recognizing the link between digestive health and overall well-being, it is not surprising this category is the largest amongst biotic products.
ADM's most recent clinical study uses the dual probiotic and postbiotic Bifidobacterium longum ES1 in a population of adults with IBS-D. In this webinar, the speaker will walk through the main findings from this study and the science around digestive health and postbiotics.
By attending this webinar, the attendees will gain insights into the following:
- Latest clinical trial data from a large multi-centre randomized controlled trial
- Explore the use of postbiotics for digestive health
- First human clinical data for a dual pro- and post-biotic
Register for this webinar today to explore invaluable insights from a large multi-center randomized controlled trial and the first human clinical data for a novel dual pro- and postbiotic for IBS-D.
Join Richard Day, VP of Medical Affairs, ADM, for the live webinar on Tuesday, June 4, 2024, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Postbiotics: Novel Solutions for Digestive Health.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
![](https://rt.prnewswire.com/rt.gif?NewsItemId=UN15310&Transmission_Id=202405160830PR_NEWS_USPR_____UN15310&DateId=20240516)
Share this article